NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

The North Carolina Biotechnology Center awarded 21 grants and loans totaling more than $1.9 million to universities and biosciences companies and other entities in the fourth quarter of its fiscal year.
Seqirus, the global vaccine maker with a mega factory in Holly Springs, has just begun to ship its portfolio of seasonal flu vaccines to healthcare providers across the United States. It is prepared to supply approximately 60 million doses to meet demand for the 2021-2022 flu season.
Bluebird bio, a Massachusetts-based gene and cell therapy company with operations in North Carolina, will sell its Durham biomanufacturing plant to National Resilience for $110 million as part of a strategic alliance between the two companies.
NIEHS’s 24th annual Biomedical Career Symposium will be held virtually on Thursday and Friday, August 26 and 27.
If you're interested in a life sciences career, mark your calendar for Wednesday, August 4 when BioNetwork hosts its fifth virtual career fair in partnership with biopharmaceutical and life sciences companies from across the state.
Raleigh emerged as the No. 5 metro area in the latest Wall Street Journal/Realtor.com Emerging Housing Markets Index, while Burlington hit #19 and Durham-Chapel Hill ranked #22 among the nation's top 300 markets.
RTP regenerative health company Merakris Therapeutics is providing a new eye-care product to eye surgeons and their patients in the Carolinas and Texas, thanks to a partnership with Winston-Salem nonprofit Miracles in Sight.
North Carolina has one of the largest biopharma manufacturing industries in the nation, and a well-coordinated workforce development network is providing the right stuff to keep it growing.
A compound developed by Rukiyah Van Dross-Anderson, Ph.D., an associate professor at ECU, with grant support from NCBiotech, could lead to more-effective skin cancer treatments.
Two teams of researchers from the Wake Forest Institute for Regenerative Medicine have won top awards and a combined $400,000 in a five-year NASA competition, beating nine other teams and creating viable vessel tissue from human cells.
Kriya Therapeutics is poised to revolutionize gene therapies for highly serious diseases like diabetes and severe obesity after landing a whopping $100 million in capital.
Bioventus logo
.

Durham-based Bioventus, a global med tech company which went public earlier this year, is releasing a new product to its lineup that uses human tissue to improve bone fusions.

A new training program at Durham Tech will prepare students for good-paying entry-level jobs in North Carolina’s growing agricultural biotechnology industry beginning this fall
Durham-based Xilis has raised $70 million in Series A financing to advance its precision oncology platform.
Cary med tech startup Lucerno Dynamics has landed a critical partnership with Siemens Healthineers, one of the world's largest healthcare suppliers.
scroll back to top of page